The stampede is back on among venture capital firms to raise new money and close more funds, after years of standing pat following the recession and years of sluggish recovery.
{iframe}http://www.genengnews.com/insight-and-intelligenceand153/20-top-vc-firms-for-biotechs/77900324/{/iframe}